Citi is set to pull out its consumer banking business in the Mexican market. The investment banking company announced on Tuesday, Jan. 11, that it is preparing for the exit of its consumer, small and middle-market banking operations in Mexico.
Citi said that this is part of its plan to advance its strategic goals of investing in businesses in line with its core strengths and to simplify the bank’s operations then push for long-term shareholder value. Then again, despite the withdrawal of its consumer banking in Mexico, Citi will maintain its presence in the country through investments via its own Institutional Clients Group.
Reuters reported that as Citi exits in the Mexican market, it will be focusing its consumer banking business on global wealth in the United States. It will also work more on payments and lending in its home ground to boost its retail presence there. It should be noted that Citi’s departure in Mexico does not include the company’s institutional business.
At any rate, with the exit, Citigroup Inc. will be officially ending its two-decade-long retail business in the region. This is also the last of the company’s consumer banking biz outside of the U.S. as it also pulled out in other countries such as South Korea.
“The strategy refresh Citi has undertaken will result in a stronger, more focused bank. We will execute a targeted consumer strategy, double down in wealth, and focus on our higher-returning institutional businesses where we have competitive advantages,” Citi’s chief financial officer, Mark Mason, said in a press release. “Our emphasis is on opportunities where our global network uniquely positions us to support clients who are growing and facing an ever-changing set of complex dynamics around the world.”
Finally, Jane Fraser, Citi’s chief executive officer, said that their move is expected to be very beneficial because it was planned “in keeping with the strategy refresh.” She also noted that they have also pulled out in many Asian locations as they discovered their consumer businesses there did not have enough size and market share to compete in the industry.


AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Yen Edges Higher as Weak US Data Dampens Fed Rate Hike Expectations
European Stocks Edge Higher as Fed Rate Pause Bets Rise
Japan Economy Grows 1.1% in Q2 as Consumer Spending Stalls
Australian Consumer Sentiment Jumps 6% in August as Rate Outlook Improves
Tesla Roadster Reveal Could Feature SpaceX Thrusters in August
US Dollar Slips as Soft Economic Data Eases Fed Rate Hike Expectations
Morgan Stanley Sees Fed Holding Rates as U.S. Inflation Cools
Bernstein Picks BYD and Xiaomi as Top China EV Stocks Despite Weaker Demand
Colombia Earthquake Losses Estimated at $9.58 Billion as Reconstruction Challenge Mounts
Ferrari Luce EV Sells for Record $40 Million at Charity Auction
Oil Prices Rise as Iran-U.S. Tensions Threaten Strait of Hormuz Supply
US Stock Futures Mixed as Fed Rate Hike Bets Fade, AI Deals in Focus
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Synlait Milk Denies Fonterra, a2 Milk Takeover Talks 



